Table 2.
Comparison between subjects with and without OPLL.
| OPLL | non OPLL | p-value | |
|---|---|---|---|
| Total No of subjects | 120 | 1669 | |
| Age -yr | 63.3 ± 10.4 | 58.2 ± 11.2 | <0.001 |
| Male Sex - no. (%) | 96 (80%) | 1020 (61%) | <0.001 |
| BMI > 25 (kg/m2) - no. (%) | 53 (44%) | 513 (30%) | 0.002 |
| Hypertension - no. (%) | 34 (28%) | 269 (16%) | 0.001 |
| HbA1c > 6.5% - no. (%) | 24 (20%) | 185 (11%) | 0.003 |
| TG > 150 mg/dL- no. (%) | 35 (29%) | 348 (21%) | 0.03 |
| UA > 7.0 mg/dL - no. (%) | 25 (21%) | 278 (17%) | 0.239 |
| IMT > 1.1 cm - no. (%) | 20 (17%) | 224 (13%) | 0.33 |
| Presence of plaque - no. (%) | 54 (45%) | 385 (23%) | <0.001 |
OPLL, ossification of the posterior longitudinal ligament; BMI, body mass index; HbA1c, glycated hemoglobin; TG, triglyceride; UA, uric acid; IMT, intima-media thickness.